Lexaria Bioscience Corp (LEXX)

[damAcon1]

You're right. I realized calling it a 'debt write off' was inaccurate, I was just trying to find a generic way of describing their RS...instead of listing the the thoughts going through my head. The RS was a necessity for them to stay above a certain value to remain listed on the NYSE. The post split price point could possibly re-entice institutional investors. The limited amount of shares available could lessen the number of shorts. And (the main reason for my calling it what I did) the new share price has the potential to keep them from breaching debt covenants if, like most if their previous convertible debentures, the contract was dependent on stock price.

Sorry, but for the sake of LXRP and board integrity, I am done discussing their company on this board. They have enough verbosity from the plumpers and dumpers on their own forum...and quite frankly...there are other more interesting cannabis companies out there to focus on.